
S6 Ep42: Jabbour Highlights New Data With Asciminib and Ponatinib in CML
OncLive® On Air
00:00
Dose-Reduction Dynamics from PACE and OPTIC
Elias Jabbour presents pooled data demonstrating dose adjustments based on response preserve efficacy and improve safety.
Play episode from 10:02
Transcript


